Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Items 401–500 of 1,001
Alzheimer's Disease and Stroke: A Tangled Neurological Conundrum
Gupta, A., Uthayaseelan, K., Uthayaseelan, K., Kadari, M., Subhan, M., Parel, N. S., Krishna, P. V., & Sange, I. (2022) · Cureus · doi:10.7759/cureus.25005 · Cited by 9
“Low-to middle-income countries witnessed a doubled incidence of stroke between 1990 and 2016 [14].”
InfluentialSengking, J., Oka, C., Yawoot, N., Tocharus, J., Chaichompoo, W., Suksamrarn, A., & Tocharus, C. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00568-6 · Cited by 8
“These changes lead to glutamate excitotoxicity, where neuronal cells become overloaded with calcium (Ca2+) in their cytosol, the primal phenomenon occurring after occlusion (Kuriakose and Xiao 2020; Sekerdag et al.”
BackgroundPamungkas, Y., Wibawa, A. D., & Cahya, M. D. (2022) · Kinetik Game Technology Information System Computer Network Computing Electronics and Control · doi:10.22219/kinetik.v7i4.1535 · Cited by 9
Naro, A., & Calabrò, R. S. (2022) · Brain Sciences · doi:10.3390/brainsci12111511 · Cited by 12
Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke
Choudhary, M., Chaudhari, S., Gupta, T., Kalyane, D., Sirsat, B., Kathar, U., Sengupta, P., & Tekade, R. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041036 · Cited by 9
“The vast proportion of strokes are ischemic, brought on by an occlusion in an artery [62].”
BackgroundKitamura, T., Terashima, T., Katagi, M., Ohashi, N., Nozaki, K., & Tsuji, A. B. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.07.003 · Cited by 7
Role of Ultrasound-Based Therapies in Cardiovascular Diseases
Bansal, A., Bulwer, B. E., von Krüchten, R., Singh, J., Rehan, R., & Doost, A. (2024) · Structural Heart · doi:10.1016/j.shj.2024.100349 · Cited by 9
Andrés, M. J. A., Molina, M., Pérez, J. G., Pina, S., Tapiador, N., de la Calle, B., Martínez, M., Ortega, P., Ruspaggiari, M. B., Tudela, C., et al. (2024) · Toxins · doi:10.3390/toxins16080340 · Cited by 8
“Moreover, most of these individuals had experienced an ischemic stroke within the middle cerebral artery, which is largely consistent with previous studies [2,27–29].”
BackgroundResultInfluentialWang, Y., Chen, X., Wang, M., Pan, Y., Li, S., He, M.-F., Lin, F., & Jiang, Z.-L. (2024) · Neural Plasticity · doi:10.1155/np/8737366 · Cited by 8
Svejgaard, B., Modrau, B., Hernández-Gloria, J. J., Wested, C. L., Dosen, S. S., Stevenson, A. J. T., & Mrachacz‐Kersting, N. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00452.2024 · Cited by 9
Mao, F.-L., He, X., Huang, X. J., Cheng, Y.-M., Qin, F., & Wang, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1469152 · Cited by 9
“Stroke, a prevalent cerebrovascular disease, has emerged as one of the foremost causes of disability and death worldwide, posing significant challenges to public health (1, 2).”
Stroke and associated comorbidities in Southeast Asian countries
Datta, A., Akundi, S., Wagh, K., Bhurle, G., Sarmah, D., Sharma, A., Shah, S., Borah, A., Saraf, S., & Bhattacharya, P. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.71 · Cited by 10
Basem, J. I., Mani, R., Sun, S., Gilotra, K., Dianati‐Maleki, N., & Dashti, R. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1525966 · Cited by 9
Alhawiti, N. M., Elsokkary, E. M., Aldali, J. A., & Alotaibi, B. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-95305-2 · Cited by 7
Psychiatric symptoms in stroke patients: Clinical features of depression and anxiety
Li, J.-M., Long, S.-S., Lu, T.-X., Jiang, Y.-C., Zhang, X.-W., & Ren, Y.-Q. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i6.103888 · Cited by 25
Lim, V. J. T., Tabassum, N. I., Orian, J. M., Arumugam, T. V., & Weng, E. F.-J. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.05.003 · Cited by 7
Soh, W. K., & Rajapakse, J. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-04819-2 · Cited by 8
Ma, F., Yuhang, Y., Qiuqin, H., Yuewang, Y., Ce, G., Yilin, W., Xiaoru, L., Jiacheng, Y., wei, Z., & Xiamin, H. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110677 · Cited by 7
Tatar, S., Tokgöz, O. S., & Selvi, Ü. G. (2025) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2024.0337r1.14072025 · Cited by 7
Sabet, H., Abbas, A., Zanaty, M. A., Elyamany, Z., El-Moslemani, M., Pereira, M. A. O. M., Al-Mufti, J., Abdelnaby, R., & Elfil, M. (2026) · International Journal of Neuroscience · doi:10.1080/00207454.2026.2628832 · Cited by 7
“Introduction Stroke affects nearly 13.7 million people and is responsible for about 5.5 million deaths each year, making it the second leading cause of death [1].”
InfluentialLiao, Y., Zheng, Q., Huang, P., Xie, Q., Wang, G., Lai, Y.-T., Jiang, X.-Y., & Ge, L. (2022) · Nursing Open · doi:10.1002/nop2.1354 · Cited by 6
Kumar, M., Kaur, K., & Singh, T. G. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08728-9 · Cited by 9
“…(tGCI) has cardiovascular origins that completely or partially disturb cerebral blood flow (CBF) causing a range of abnormalities in the brain (Kuriakose & Xiao, 2020) such as mitochondrial dysfunction, energy failure, free radicals, inflammatory cytokines, and excitotoxicity-related…”
BackgroundWang, J., He, P., Tian, Q., Luo, Y., He, Y., Liu, C., Gong, P., Guo, Y., Ye, Q., & Li, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367831 · Cited by 8
“It also can lead to disability in some patients despite appropriate therapy (Barthels and Das, 2020; Kuriakose and Xiao, 2020).”
BackgroundUnderstanding the Therapeutic Approaches for Neuroprotection
Payal, N., Sharma, L. K., Sharma, A., Hobanii, Y. H., Hakami, M., Ali, N., Rashid, S., Sachdeva, M., Gulati, M., Yadav, S., et al. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128275761231103102125 · Cited by 9
Baspakova, A. M., Abitova, A. Z., Mussin, N. M., Kaliyev, A. A., Yerimbetova, G., Zhumagaliyeva, S., Ashimova, Z., Zhilisbayeva, K. R., Umbetova, A. A., Nurtazina, A., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1333887 · Cited by 7
“Strokes can be caused by a blockage or bleeding in the brain (9).”
BackgroundYang, L., & Wang, M. (2024) · The Neurologist · doi:10.1097/nrl.0000000000000561 · Cited by 10
“42 Furthermore, our conclusions demonstrated that individuals with a proin fl ammatory dietary pattern (DII > 0) have considerably increased risks of all-cause mortality and CVD-related mortality compared with those with an anti-in fl ammatory dietary pattern (DII 0).”
Stroke and Transient Ischemic Attack
Banyas, P., & Jadhav, A. P. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.02.004 · Cited by 7
Liu, D., Song, C., Lv, C., & Zhang, A. (2024) · Shock · doi:10.1097/shk.0000000000002348 · Cited by 9
“The pathological mechanism of CIRI mainly includes oxidative stress, interruption of blood flow, excitotoxicity, inflammatory response, and other factors (25).”
BackgroundStem cell therapy as a promising approach for ischemic stroke treatment
Yaqubi, S., & Karimian, M. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100183 · Cited by 13
“Stroke is the result of obstruction or rupture of blood vessels, and almost more than 80% of all stroke cases are ischemic, which are usually caused by blockage of the middle cerebral artery (Kuriakose and Xiao, 2020; Tajalli-Nezhad et al., 2019; Vahidinia et al., 2021).”
BackgroundBukke, S. P. N., Gali, A. K., Igbinoba, S. I., Venkateswarlu, G., Bello, H., Goruntla, N., & Onohuean, H. (2024) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqae015 · Cited by 7
Rasouli, A., Roshangar, L., Hosseini, M., Pourmohammadfazel, A., & Nikzad, S. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.06.031 · Cited by 7
Altered Resting-State Electroencephalogram Microstate Characteristics in Stroke Patients
Lu, H., Ma, Z., Zhang, J.-P., Wu, J., Zheng, M., Hua, X., & Xu, J. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2309176 · Cited by 7
“The number of repetitions for the clustering procedure for each K (K = [2–8]) was 100 to choose the microstate templates with maximum global explained variance (GEV) which referred to the percentage of total variance explained by a specific microstate [43].”
MethodGlobal, regional, and national burden of ischemic stroke attributable to active smoking, 1990-2021
Pang, M., Hou, S., Xia, X., Wang, G., Wang, Y., Wang, L., & Li, X. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/194697 · Cited by 8
Role of microRNA in the risk stratification of ischemic strokes
Al-Jehani, H. M., Mousa, A. H., Alhamid, M. A., & Al‐Mufti, F. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1499493 · Cited by 7
Kim, D. H. J., Gagolewicz, P. J., McQueen, S. A., Latour, H., Tresidder, K. A., Jarvis, C. R., & Andrew, R. D. (2025) · Journal of Neurophysiology · doi:10.1152/jn.00429.2024 · Cited by 9
Exploring Hypoxia-Induced Neuroprotection Mechanisms in Post-Stroke Recovery
Nyamukondiwa, M., Koneva, E. S., Achkasov, E. E., Zhang, X., Padmanabha Reddy, Y., Beeraka, N. M., & Glazachev, O. S. (2025) · Translational Stroke Research · doi:10.1007/s12975-025-01364-y · Cited by 9
“IHHE may stimulate EPO production, supporting recovery through enhanced neurogenesis and tissue protection in ischemic zones [12, 13, 48–52].”
InfluentialStamenković, M., Radmilo, L., Jovicevic, M., Rabi-Žikić, T., Žarkov, M., Ružička-Kaloci, S., Simić, S., Stamenković, A., Dangić, J., Knezovic, G., et al. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106483 · Cited by 8
“Also, according to their results, the predominant risk factor is arterial hypertension (65% and more), but diabetes mellitus (about 15-30%) and atrial fibrillation (15-25%) are also very important.(17-19) Comparing demographic data (age and gender), as well as data on risk factors for stroke in our study with the epid…”
Jung, H. Y., Kwon, H. J., Kim, W., Hahn, K. R., Moon, S. M., Yoon, Y. S., Kim, D. W., & Hwang, I. K. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105346 · Cited by 7
A statistical analysis of acute ischemic stroke before and during the COVID-19 pandemic
Coculescu, B.-I., Stocheci, C. M., Totan, A., & Coculescu, E. C. (2022) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2022.1.7 · Cited by 8
Tian, Q., Hua, Y., Li, J., Jiang, J., Ren, B., & Liu, J. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04009-0 · Cited by 7
“The ischemic stroke is the predominant type of stroke, which occurs due to the ischemic occlusion in the brain [33].”
BackgroundLi, H., Zhang, L., Wang, W., Xiang, D., Zhang, Z., & Mei, Y. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062859 · Cited by 9
Overground Robotic Gait Trainer mTPAD Improves Gait Symmetry and Weight Bearing in Stroke Survivors
Stramel, D. M., Winterbottom, L., Stein, J. M., & Agrawal, S. K. (2023) · Bioengineering · doi:10.3390/bioengineering10060698 · Cited by 7
“Stroke is the second leading cause of disability and death in adults, resulting from damage to brain cells due to a temporary blockage of blood flow to the brain or bleeding in surrounding brain tissue [1].”
Backgroundcis P-tau Accumulation Triggers Neurodegeneration after Ischemic Stroke
Seddigh, N., Taabodi, D., Dadzadi, M., & Shahpasand, K. (2024) · ACS Omega · doi:10.1021/acsomega.3c07285 · Cited by 9
Eye Movement in Neurological Disorders
Das, J., Graham, L., Morris, R., Barry, G., Godfrey, A., Walker, R. W., & Stuart, S. (2022) · Neuromethods · doi:10.1007/978-1-0716-2391-6_11 · Cited by 8
Romano, F., Formenti, D., Cardone, D., Russo, E. F., Castiglioni, P., Merati, G., Merla, A., & Perpetuini, D. (2024) · Entropy · doi:10.3390/e26070578 · Cited by 8
“…studies have highlighted specific signs and symptoms that differentiate between hemorrhagic and ischemic strokes, including decreased consciousness [1], dilated pupils, agitation, severe headache, lower Glasgow Coma Scale (GCS) scores, seizures, and eye gaze impairments at higher rates than…”
BackgroundA review of cell death pathways in hemorrhagic stroke
Rinald, J. H., & Troy, C. M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1570569 · Cited by 9
Chien, S.-Y. (2025) · Digital Health · doi:10.1177/20552076251340183 · Cited by 7
Chen, C., Cao, L., Xue, M., & Zhu, N. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin37182 · Cited by 6
Family Caregiver’s Perception of Resilience in Caring for Stroke Patients: A Qualitative Research
Nooreddini, A., Sadeghian, E., Borzou, S. R., Ghiasian, M., & Sotanian, A. (2025) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/ijnmr.ijnmr_106_24 · Cited by 9
“[3] As a result, this improves the endurance of patients.”
Moghib, K., Hefnawy, M. T., Moawad, S. M., Salomon, I., Hamdi, A., Uwishema, O., & Meshref, M. M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1649476 · Cited by 8
“This neurological disorder is characterized by notable impairments in motor function, often resulting in weakness or paralysis (34).”
Wang, H., Qiao, Y., Lu, H., Xiao, L., & Cheng, Q. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.10.036 · Cited by 7
Chen, Y., Yang, B., Xu, L., Shi, Z., Han, R., Yuan, F., Ouyang, J., Xu, Y., & Ostrikov, K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.875053 · Cited by 6
A Bibliometric Analysis of Stroke Caregiver Research from 1989 to 2022
Suliman, M. A. B., Hanis, T. M., Kamdi, M. K. A., Ibrahim, M. I., & Musa, K. I. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054642 · Cited by 8
“Many family members reported they did not anticipate the stroke attack, and most were unprepared for the consequences [2].”
BackgroundGümbel, D. C., Tanislav, C., Konrad, M., Jacob, L., Koyanagi, A., Smith, L., & Kostev, K. (2023) · Healthcare · doi:10.3390/healthcare11131913 · Cited by 7
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
Плотников, М. Б., Чернышева, Г. А., Smol’yakova, V. I., Алиев, О. И., Анищенко, А. М., Ulyakhina, O. A., Трофимова, Е. С., Ligacheva, A. A., Anfinogenova, Y., Osipenko, A. N., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16081057 · Cited by 10
Yılmaz, E., Baltacı, S. B., Moğulkoç, R., & Baltacı, A. K. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2296165 · Cited by 7
“87% of stroke cases are ischemic strokes caused by blockage of blood fl ow while the remaining cases are hemorrhagic strokes due to bleeding into the brain tissue [23].”
Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound
Koga, T., Kida, H., Yamasaki, Y., Feril, L. B., Endo, H., Itaka, K., Abe, H., & Tachibana, K. (2024) · Nanomaterials · doi:10.3390/nano14030285 · Cited by 8
“…and Parkinson’s disease [22,23]; Parkinson’s syndrome [24,25]; spinocerebellar degeneration [26–28] resulting from the accumulation of pathogenic proteins in neurons and glial cells; and stroke, such as cerebral hemorrhage, due to the blockage or rupture of blood vessels that feed the brain [29].”
BackgroundNeuroprotective Therapeutic Potential of microRNA-149-5p against Murine Ischemic Stroke
Vahidi, S., Bigdeli, M., Shahsavarani, H., Ahmadloo, S., & Roghani, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04159-8 · Cited by 6
“Ischemic stroke (IS), a devastating neurological disorder, is a leading global cause of death and disability [1].”
Purwwokerto, U. A., Tikaningsih, A., Lestari, P., Nurhopipah, A., Tahyudin, I., Winarto, E., & Hassa, N. (2024) · Telematika · doi:10.35671/telematika.v17i1.2816 · Cited by 6
Machine learning-driven predictions and interventions for cardiovascular occlusions
Thomas, A., Jose, R., Syed, F., Wei, O. C., & Toma, M. (2024) · Technology and Health Care · doi:10.3233/thc-240582 · Cited by 6
Lage, T. A. R., Rocha, M. O. D. C., Tupinambás, J. T., Botoni, F. A., de Pádua, L. B., Mutarelli², A. M., Silva, J. L. P., Martins, M. A. P., Teixeira, A. L., & Nunes, M. C. P. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132628 · Cited by 6
HANNES: A Modular Neurointerventional Training Model
Schmiech, J., Wegner, M., Wortmann, N., Sobirey, E., Guerreiro, H., Kyselyova, A. A., Ramdani, N., & Krause, D. (2024) · Journal of Engineering and Science in Medical Diagnostics and Therapy · doi:10.1115/1.4066935 · Cited by 6
Adil, M., Jiba, U., Khan, A. A., Shahrukh, M., Hasan, N., & Ahmad, F. J. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106318 · Cited by 8
Clain, J., Couret, D., Bringart, M., Meilhac, O., d’Hellencourt, C. L., & Diotel, N. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.12.002 · Cited by 7
Wodu, C. O., Sweeney, G., & Kerr, A. (2024) · Journal of Hand Therapy · doi:10.1016/j.jht.2024.08.005 · Cited by 7
Qian, H., Zhou, S., Qian, R., Li, Q., Zhang, J., Ding, Y., & Wang, C. (2024) · Human & Experimental Toxicology · doi:10.1177/09603271241304372 · Cited by 6
Association between serum A/G ratio and stroke: data from NHANES 2009–2020
Tan, X., Lv, C., Lü, C., Luo, Y., & Mei, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1512165 · Cited by 6
Huang, X., Wu, Y.-C., & Lu, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1524099 · Cited by 6
“There are multiple mechanisms involved, such as inflammation, oxidative stress, and ionic imbalance (2, 3).”
Therapeutic Potential of Mesenchymal Stem Cells in Stroke Treatment
Choudhery, M. S., Arif, T., Mahmood, R., & Harris, D. T. (2025) · Biomolecules · doi:10.3390/biom15040558 · Cited by 8
“The brain neurons become deprived of the required energy and oxygen due to the disruption in the blood flow [14].”
Carotid artery stiffness measured by strain elastography ultrasound is a stroke risk factor
Tjan, A., Widiana, I. G. R., Martadiani, E. D., Ayusta, I. M. D., Asih, M. W., & Sitanggang, F. P. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100850 · Cited by 6
The Clinical Value of Circulating MicroRNAs in Acute Ischemic Stroke
Salman, A., Elshaer, S. S., Shafei, A. E., & Shaker, O. G. (2021) · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2021.79177.1078 · Cited by 8
A Review on Therapeutic Potential of Natural Phytocompounds for Stroke
Almutairi, F. M., Ullah, A., Althobaiti, Y. S., Irfan, H. M., Shareef, U., Usman, H., & Ahmed, S. (2022) · Biomedicines · doi:10.3390/biomedicines10102566 · Cited by 9
“In addition, the prevalence of ischemic stroke in young adults is increasing, implying the need for targeted preventive measures in that age group [4,5].”
BackgroundSafiullov, Z. Z., Izmailov, A., Sokolov, M. E., Аршалуйсович, М. В., Kundakchan, G., Garifulin, R. R., Шмаров, М. М., Naroditsky, B. S., Logunov, D. Y., & Islamov, R. R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102209 · Cited by 6
“addressed, along with apoptosis and neuroinflammation to prevent brain cell death [3].”
BackgroundBabataheri, S., Malekinejad, H., Mosarrezaii, A., & Soraya, H. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12856 · Cited by 7
“Ischemic stroke is more frequent and includes 87% of cases [2].”
BackgroundLing, H., Guo, H., Zhou, H., Chang, X.-Q., Guo, Z., Yamamoto, S., Cai, L.-F., & Zhao, J. F. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01068-0 · Cited by 6
“Background Stroke is the primary cause of mortality and disability for adults [1].”
BackgroundSanto, B. A., Ciecierska, S.-S. K., Sarayi, S. M. M. J., Jenkins, T. D., Baig, A. A., Monteiro, A., Koenigsknecht, C., Pionessa, D., Gutierrez, L. C., King, R. M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14837 · Cited by 6
An introduction on cerebrovascular aneurysms during pregnancy
Saravani, K., Mirsarzai, Z., & Sekhavati, M. (2021) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2021.356664.1057 · Cited by 6
Chen, X., Shao, Y., Linfeng, Z., Tang, S., Lai, Z., Sun, X., Xie, F., Xie, L., Luo, J., & Hu, D.-X. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1153252 · Cited by 6
“Stroke (Kuriakose and Xiao, 2020) is a leading cause of death and disability worldwide, with over 80% of stroke survivors suffer from upper limb motor function impairment with great pain (Hatem et al.”
BackgroundYan, K.-Q., Wu, Q.-S., & Yang, J. (2023) · Chinese Medical Sciences Journal · doi:10.24920/004219 · Cited by 6
Ali, N. H., Abdullah, A. R., Saad, N. M., & Muda, A. S. (2023) · International Journal of Power Electronics and Drive Systems/International Journal of Electrical and Computer Engineering · doi:10.11591/ijece.v13i5.pp5843-5852 · Cited by 11
“Over 85% of stroke patients lose their lives as a result of ischemic occlusions [3], with intracerebral hemorrhage contribute the remaining 15%.”
Comparative effectiveness of different treatments for post-stroke insomnia: A network meta-analysis
Song, Z., Chen, Y., Li, J., Chen, Z., Lu, X., & Wang, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21801 · Cited by 7
Progressive lesion necrosis is related to increasing aphasia severity in chronic stroke
Johnson, L., Newman‐Norlund, R., Teghipco, A., Rorden, C., Bonilha, L., & Fridriksson, J. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103566 · Cited by 7
“While the pathophysiology of and neuronal recovery patterns associated with the acute stage of stroke have been well-defined (Kuriakose and Xiao, 2020; Alia et al., 2017; Seitz and Donnan, 2015), explanations of analogous changes in the chronic stage of recovery remain largely unexplored.”
Kotalczyk, A., Guo, Y., Fawzy, A. M., Wang, Y., & Lip, G. Y. H. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12744 · Cited by 5
EVENTOS ADVERSOS NA UNIDADE DE TERAPIA INTENSIVA
Sanches, V. T. B., Martins, M. D. J. S., & Pereira, R. P. (2023) · Editora Conhecimento Livre eBooks · doi:10.37423/230707986 · Cited by 6
Kim, H. H., Han, A., Lee, H.-J., Choi, J., Lee, H., & Cho, M. (2024) · Healthcare · doi:10.3390/healthcare12191913 · Cited by 16
“Stroke has uncontrollable risk factors, such as age, sex, genetics, and race, and controllable risk factors regulated through self-care, such as chronic disease management, smoking, alcohol consumption, and physical activity [1].”
BackgroundA narrative review of vagus nerve stimulation in stroke
Hu, Y. J., Xiong, R., Pan, S., & Huang, K. (2024) · Journal of Central Nervous System Disease · doi:10.1177/11795735241303069 · Cited by 9
Therapeutic Role of Microglia/Macrophage Polarization in Intracerebral Hemorrhage
Dinç, R., & Ardıç, N. (2025) · Clinical and Translational Neuroscience · doi:10.3390/ctn9010004 · Cited by 6
“The middle cerebral artery (MCA), part of the circle of the Willis anastomotic system that supplies blood to a wide area of brain tissue, is highly vulnerable and is associated with the majority of stroke-related disability [10,11].”
de Witte, A., Sanchez, J. M., Daniele, E., Chen, J., Fan, Y., Khatri, P., Casasbuenas, D. L., Zhang, A., Todd, K. G., Faiz, M., et al. (2025) · BMC Neuroscience · doi:10.1186/s12868-025-00959-3 · Cited by 5
“…microglial responses but does not improve outcomes in a mouse model of endothelin-1 sensory motor stroke Background Ischemic stroke, caused by occlusion of a cerebral artery, leads to decreased blood supply and oxygenation that results in neuronal death and neurological deficits [1, 2].”
D’Arrigo, C., Labbate, S., & Galante, D. (2025) · Stem Cells International · doi:10.1155/sci/2616653 · Cited by 8
Fan, W., Fang, Z., Weng, Y., Zhan, T., Huang, K., Pan, J., & Zhan, R. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70050 · Cited by 5
“9 However, reperfusion following stroke often results in cerebral ischemia/reperfusion (CI/R) injury, which can exacerbate neuronal damage.”
Bumbea, A. M., Glăvan, D., Vasile, R.-C., Rotaru-Zăvăleanu, A. D., Greșiță, A., Surugiu, R., Dinescu, S. N., Burlacu, I., & Aldea, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217735 · Cited by 7
“This deprivation leads to tissue death and often results in long-term physical and cognitive deficits [5,6].”
Rewiring Brain Recovery: Astrocyte–Neuron Metabolic Cooperation in Stroke
Lu, W., Jiang, Z., & Wen, J. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864251411183 · Cited by 7
“During ischemic stroke, brain tissue cells experience abnormal energy metabolism due to regional cerebral blood supply abnormality, cerebral vascular stenosis or occlusion, focal ischemia, and hypoxia (Kuriakose and Xiao, 2020).”
Research Progress of Ferroptosis in Cerebral Infarction
Fei, Y., & Leng, Q. (2026) · Brain and Behavior · doi:10.1002/brb3.71192 · Cited by 8
“The pathological cascade following cerebral infarction involves a complex interplay of excitotoxicity, oxidative stress, inflammation, and various forms of cell death (Kuriakose and Xiao 2020 ).”
InfluentialLin, J., Cai, C., & Xie, Y. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1837-0141 · Cited by 6
Novel Lipid Mediators as a Promising Therapeutic Strategy for Ischemic Stroke
Belayev, L., Reid, M. M., & Bazan, N. G. (2023) · Medical Research Archives · doi:10.18103/mra.v11i1.3333 · Cited by 6
Tyler, S. E. B., & Tyler, L. D. K. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100094 · Cited by 7
Sharma, V. S., Sharath, H. V., & Sasun, A. R. (2024) · Cureus · doi:10.7759/cureus.59314 · Cited by 5
“These vessels provide blood supply to parts of the frontal, temporal, and parietal lobes of the brain, as well as deeper structures, including the caudate, internal capsule, and thalamus [3].”
BackgroundQin, J., Chen, K., Wang, X., He, S., Chen, J., Zhu, Q., He, Z., Lv, P., & Chen, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116271 · Cited by 8
“Cerebral infarction, namely ischemic stroke (IS), is a nervous system disease characterized by vascular obstruction [1,2].”
BackgroundVictor, B. A., Arunachalam, R., Angel, S., & Gnanesh Kumar, B. (2024) · Cureus · doi:10.7759/cureus.66299 · Cited by 5
“…to determine which symptom is the sole physiological consequence of the cerebrovascular accident; these medical conditions emanate from an entire spectrum of psychological distress corresponding to the incident, its subsequent effects, and cognitive impairment brought on by the lesion [2].”
BackgroundZeng, X., Fan, L., Qin, Q., Zheng, D., Wang, H., Li, M., Jiang, Y., Wang, H., Liu, H., Liang, S., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.042 · Cited by 5
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


